+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Paediatric Healthcare Market by Product Type (Medical Devices, Nutritional Supplements, Therapeutics), Route Of Administration (Oral, Parenteral, Topical), Inidication, Delivery Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968855
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Paediatric Healthcare Market grew from USD 114.55 billion in 2024 to USD 123.45 billion in 2025. It is expected to continue growing at a CAGR of 7.62%, reaching USD 178.08 billion by 2030.

Comprehensive Overview of Evolving Paediatric Healthcare Trends Shaping Market Dynamics and Stakeholder Strategies in the Modern Healthcare Ecosystem

The paediatric healthcare landscape has undergone significant evolution driven by demographic shifts, technological advancements, and changing payer and provider priorities. Rising awareness of early-life health imperatives has led to increased focus on preventive measures, while chronic paediatric conditions have prompted the adoption of novel therapeutic approaches. As healthcare ecosystems become more interconnected, stakeholders seek comprehensive visibility into patient journeys, supply chains, and emerging modalities that promise enhanced efficacy and safety profiles for young patients.

Against this backdrop, this executive summary synthesises key trends and critical insights that define the current paediatric healthcare milieu. By outlining the transformative forces at play, the cumulative impact of trade policies, and refined market segmentation, readers will gain a holistic understanding of both structural drivers and tactical imperatives. This document serves as a strategic compass for decision-makers aiming to capitalise on growth opportunities, mitigate supply chain risks, and forge innovative partnerships in a sector where precision and agility are paramount.

Identifying Transformative Shifts Redefining Paediatric Healthcare Delivery Through Digital Innovation Personalized Therapeutics and Value-Based Care Models

Digital innovation and value-based care models are reshaping the delivery of paediatric healthcare at an unprecedented pace. Telehealth platforms have bridged geographical barriers, enabling remote monitoring and virtual consultations that reduce hospital stays and streamline routine follow-ups. Concurrently, advanced analytics and artificial intelligence applications support early detection of developmental delays and chronic conditions, empowering clinicians with predictive insights that inform personalised treatment plans.

Personalised therapeutics and precision medicine have emerged as transformative paradigms, driving investments in genetic screening and biomarker-driven interventions. This shift from one-size-fits-all therapies to tailored regimens is complemented by the integration of digital health tools that engage families through mobile apps and remote patient monitoring. Moreover, the growing emphasis on patient-centric value frameworks has encouraged payers and providers to collaborate on risk-sharing models, ensuring that outcomes and patient experience metrics are aligned with reimbursement structures.

Analyzing Comprehensive Effects of United States Tariffs on Paediatric Healthcare Supply Chains Clinical Costs and Provider Strategies

Recent adjustments to import duties and trade tariffs in the United States have introduced fresh complexities for manufacturers and healthcare providers serving paediatric populations. Increased levy structures on medical equipment and active pharmaceutical ingredients have translated into higher procurement costs, prompting supply chain stakeholders to reevaluate sourcing strategies and inventory buffers. As a consequence, procurement leaders are balancing cost containment with the imperative to maintain uninterrupted access to critical devices and treatments.

In response to these headwinds, several organisations have diversified their production footprints, exploring partnerships in low-tariff regions and investing in localized manufacturing capabilities. Simultaneously, regulatory compliance teams are navigating evolving customs protocols and advising on tariff classification appeals. By reframing supply chain resilience as a competitive differentiator, leaders are leveraging technology-enabled traceability solutions and dynamic sourcing models that mitigate tariff burdens without compromising safety or quality standards.

Integrating Multi-Dimensional Segmentation Insights to Highlight Paediatric Healthcare Market Composition and Targeted Innovation Pathways

A nuanced segmentation framework reveals the heterogeneous nature of the paediatric healthcare domain and highlights targeted innovation corridors. In the realm of product portfolios, medical devices range from diagnostic and monitoring systems that capture real-time physiological data to precision-engineered surgical instruments designed for paediatric anatomy, while complementary categories encompass nutritional supplements, therapeutics, and vaccines. The selection of route of administration underscores clinical preference and patient comfort, spanning oral formulations, various parenteral delivery methods including intramuscular, intravenous, and subcutaneous injections, as well as topical modalities such as dermatological, nasal, and ophthalmic applications alongside transdermal patches.

Further clarity arises from indication-based classification, where gastrointestinal conditions such as diarrhoea and malabsorption share focus with genetic disorders and an array of infectious diseases differentiated by bacterial, fungal, or viral etiology. Neurological disorders including attention deficit hyperactivity disorder, cerebral palsy, and epilepsy demand specialized approaches, just as respiratory illnesses like asthma, bronchitis, and pneumonia shape therapeutic development priorities. Finally, the delivery mode-whether care is administered in-home through conventional visits or telehealth, in inpatient settings, or via outpatient pathways such as ambulatory surgery and day care-defines the operational context for innovation and patient engagement.

Examining Regional Variations Revealing Distinct Drivers and Opportunities Across Americas Europe Middle East Africa and Asia-Pacific Paediatric Markets

Regional dynamics in paediatric healthcare reflect diverse regulatory environments, reimbursement landscapes, and demographic pressures. In the Americas, expansive healthcare infrastructure and robust private sector participation drive demand for advanced monitoring devices and next-generation vaccine platforms, while cross-border collaboration on clinical trials accelerates therapeutic approvals. Contrastingly, Europe, the Middle East, and Africa exhibit varied adoption rates of digital health solutions, with some markets prioritizing national telehealth initiatives and others seeking regional harmonization of paediatric treatment guidelines.

Asia-Pacific stands out for its dual emphasis on affordable diagnostic tools and scalable home-care models, leveraging mobile health networks to extend specialist access to rural communities. Regional governments are piloting innovative public-private partnerships that integrate nutritional supplementation programmes with remote monitoring to combat neonatal malnutrition. As stakeholders navigate localized reimbursement frameworks and population health imperatives, they must tailor product designs and service offerings to meet unique clinical and economic thresholds across these three macro-regions.

Unveiling Competitive Dynamics Highlighting Key Paediatric Healthcare Players Advancing Growth Through Strategic Partnerships and Technological Leadership

Leading organisations are forging partnerships and driving innovation to maintain a competitive edge in paediatric healthcare. Several multinational pharmaceutical firms have established dedicated paediatric research teams, leveraging their global clinical networks to accelerate trial recruitment and optimize age-appropriate formulation development. Meanwhile, pioneering medical device manufacturers are incorporating sensor miniaturization and cloud connectivity into their product roadmaps, enabling continuous patient monitoring and seamless data integration for clinicians.

Strategic collaborations between biotech startups and established healthcare conglomerates are producing novel gene therapies and biologics, while technology companies are applying machine learning to streamline drug discovery pipelines. Mergers and acquisitions activity continues to reshape the competitive terrain, as companies seek to internalize complementary skill sets-from digital health expertise and regulatory know-how to specialized paediatric care capabilities. Together, these initiatives underscore a collective commitment to advancing paediatric healthcare outcomes through synergy and cross-sector collaboration.

Actionable Strategic Recommendations Empowering Industry Leaders to Capitalize on Emerging Paediatric Healthcare Opportunities and Navigate Regulatory Complexities

Industry leaders should prioritize the integration of digital platforms into existing care pathways to enhance remote patient engagement and operational efficiency. By forging alliances with telehealth providers and investing in interoperable data ecosystems, organisations can improve adherence monitoring and facilitate real-time clinical decision support. Simultaneously, diversifying supply chain networks and establishing dual sourcing arrangements will mitigate risks associated with tariff fluctuations and geopolitical disruptions.

Moreover, companies should engage early with regulatory authorities to co-create paediatric-specific guidelines and expedite approvals. Incorporating patient and caregiver feedback into product design can foster cost-effective solutions that address unmet clinical needs. By adopting value-based contracting models tied to measurable outcomes, payers and providers can align incentives that drive both affordability and superior patient experience. Finally, strategic investments in scalable manufacturing and localized capabilities will position organisations to respond swiftly to emergent health crises and evolving market demands.

Detailed Research Methodology Clarifying Data Collection Expert Validation and Analytical Frameworks Underpinning Paediatric Healthcare Insights

This analysis synthesizes insights derived from a structured research framework combining secondary literature review, primary stakeholder interviews, and quantitative data validation. Initial desk research involved a comprehensive examination of peer-reviewed journals, regulatory filings, and industry white papers to establish foundational market understanding. Subsequently, in-depth interviews with healthcare executives, clinicians, supply chain specialists, and regulatory experts provided contextual depth and real-world perspectives.

Data triangulation methodologies were applied to reconcile discrepancies across sources, ensuring robustness of qualitative themes and operational metrics. Analytical models incorporated segmentation variables and regional parameters, supporting comparative analyses across product types, administration routes, clinical indications, and delivery modes. Peer review cycles and expert validation panels substantiated key findings, while iterative feedback loops refined strategic recommendations to align with evolving stakeholder priorities.

Conclusive Reflections Emphasizing Critical Insights and Future Horizon for Paediatric Healthcare Innovations and Stakeholder Engagement

The paediatric healthcare sector stands at the threshold of transformative change, driven by advancements in digital medicine, precision therapies, and patient-centred care models. As trade policies evolve and regional variances shape local strategies, stakeholders must remain agile, leveraging data-driven insights to navigate complexity and seize opportunities. The confluence of technological innovation and collaborative ecosystems is poised to redefine paediatric treatment paradigms, ushering in a new era of proactive health management for young patients.

Moving forward, organisations that adopt integrated approaches-combining advanced analytics, diversified supply chains, and outcome-based contracting-will be best positioned to deliver superior clinical results and sustainable growth. Ongoing engagement with regulatory bodies and community stakeholders will further drive innovation and adoption, ensuring that paediatric healthcare continues to evolve in alignment with patient needs and public health priorities.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Medical Devices
      • Diagnostics & Monitoring Devices
      • Surgical Instruments
    • Nutritional Supplements
    • Therapeutics
    • Vaccines
  • Route Of Administration
    • Oral
    • Parenteral
      • Intramuscular
      • Intravenous
      • Subcutaneous
    • Topical
      • Dermatological
      • Nasal
      • Ophthalmic
    • Transdermal
  • Inidication
    • Gastrointestinal Disorders
      • Diarrhea
      • Malabsorption
    • Genetic Disorders
    • Infectious Diseases
      • Bacterial Infections
      • Fungal Infections
      • Viral Infections
    • Neurological Disorders
      • ADHD
      • Cerebral Palsy
      • Epilepsy
    • Respiratory Disorders
      • Asthma
      • Bronchitis
      • Pneumonia
  • Delivery Mode
    • Home Care
      • Conventional Home Visit
      • Telehealth
    • Inpatient
    • Outpatient
      • Ambulatory Surgery
      • Day Care
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Holding AG
  • AstraZeneca plc
  • Abbott Laboratories
  • Nestlé S.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of remote patient monitoring and telehealth platforms for pediatric chronic conditions
5.2. Integration of genomic sequencing and personalized medicine in newborn screening programs
5.3. Adoption of AI-driven diagnostic tools for early detection of developmental disorders
5.4. Expansion of at-home immunization and vaccination services to improve compliance rates
5.5. Development of microbiome-based therapies for management of pediatric gastrointestinal disorders
5.6. Surge in digital mental health apps tailored for adolescents facing anxiety and depression
5.7. Introduction of eco-friendly, biodegradable medical devices for neonatal intensive care units
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Paediatric Healthcare Market, by Product Type
8.1. Introduction
8.2. Medical Devices
8.2.1. Diagnostics & Monitoring Devices
8.2.2. Surgical Instruments
8.3. Nutritional Supplements
8.4. Therapeutics
8.5. Vaccines
9. Paediatric Healthcare Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
9.3.1. Intramuscular
9.3.2. Intravenous
9.3.3. Subcutaneous
9.4. Topical
9.4.1. Dermatological
9.4.2. Nasal
9.4.3. Ophthalmic
9.5. Transdermal
10. Paediatric Healthcare Market, by Inidication
10.1. Introduction
10.2. Gastrointestinal Disorders
10.2.1. Diarrhea
10.2.2. Malabsorption
10.3. Genetic Disorders
10.4. Infectious Diseases
10.4.1. Bacterial Infections
10.4.2. Fungal Infections
10.4.3. Viral Infections
10.5. Neurological Disorders
10.5.1. ADHD
10.5.2. Cerebral Palsy
10.5.3. Epilepsy
10.6. Respiratory Disorders
10.6.1. Asthma
10.6.2. Bronchitis
10.6.3. Pneumonia
11. Paediatric Healthcare Market, by Delivery Mode
11.1. Introduction
11.2. Home Care
11.2.1. Conventional Home Visit
11.2.2. Telehealth
11.3. Inpatient
11.4. Outpatient
11.4.1. Ambulatory Surgery
11.4.2. Day Care
12. Americas Paediatric Healthcare Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Paediatric Healthcare Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Paediatric Healthcare Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. GlaxoSmithKline plc
15.3.3. Sanofi S.A.
15.3.4. Johnson & Johnson
15.3.5. Merck & Co., Inc.
15.3.6. Novartis AG
15.3.7. Roche Holding AG
15.3.8. AstraZeneca plc
15.3.9. Abbott Laboratories
15.3.10. Nestlé S.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PAEDIATRIC HEALTHCARE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PAEDIATRIC HEALTHCARE MARKET: RESEARCHAI
FIGURE 24. PAEDIATRIC HEALTHCARE MARKET: RESEARCHSTATISTICS
FIGURE 25. PAEDIATRIC HEALTHCARE MARKET: RESEARCHCONTACTS
FIGURE 26. PAEDIATRIC HEALTHCARE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PAEDIATRIC HEALTHCARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DIAGNOSTICS & MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DIAGNOSTICS & MONITORING DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DERMATOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DIARRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MALABSORPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MALABSORPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ADHD, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ADHD, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CEREBRAL PALSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CEREBRAL PALSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY BRONCHITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CONVENTIONAL HOME VISIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CONVENTIONAL HOME VISIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TELEHEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY AMBULATORY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY AMBULATORY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DAY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DAY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 169. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 172. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 173. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 176. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 177. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 178. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 179. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 182. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 183. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 184. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 185. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 186. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 187. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 188. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 189. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 190. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 191. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 192. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 193. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 194. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 195. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 198. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 199. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 202. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 203. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 204. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 205. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 210. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 211. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 220. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICAL DEVICES, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INIDICATION, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY RESPIRATORY DISORDERS, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 3

Samples

Loading
LOADING...

Companies Mentioned

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Holding AG
  • AstraZeneca plc
  • Abbott Laboratories
  • Nestlé S.A.

Table Information